This section reviews trials involving the transcription factors TFEB, PPAR, and NF-B and epigenetic therapies, particularly HDACis, with a focus on their effects on the modulation of autophagy (Tables 5 and 6)
Description MOUNJARO (tirzepatide) is a once-weekly injectable prescription medication containing tirzepatide , the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Strategies to preserve muscle mass during weight loss focus on increasing protein intake to 1.6 to 2.2 grams per kilogram daily and incorporating resistance training
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation
Research Applications Sleep & Chronobiology Research DSIP has been shown to promote slow-wave (delta) sleep and normalize circadian rhythms in animal studies [1]
With the compounded medications, splitting doses was possible because the compounding pharmacies presented the GLP1s in multi-dose vials which included a preservative to maintain its effectiveness over time